These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7329598)

  • 1. Immune-induced leucopenia. A role for the aggregation of polymorphonuclear neutrophils in systemic lupus erythematosus (SLE).
    Camussi G; Segoloni G; Tetta C; Bussolino F; Stratta P; Ragni R; Vercellone A
    Minerva Nefrol; 1981; 28(3):221-3. PubMed ID: 7329598
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bisegmented neutrophils and lymphocytes in the diagnosis of leukopenia caused by systemic lupus erythematosus].
    Rivero I; Morales J
    Rev Med Chil; 1972; 100(5):526-8. PubMed ID: 5038993
    [No Abstract]   [Full Text] [Related]  

  • 3. The binding of platelet-activating factor (PAF) to polymorphonuclear neutrophils (PMN) as a trigger for the immune-induced PMN aggregation.
    Camussi G; Bussolino F; Tetta C; Brusca R; Ragni R
    Panminerva Med; 1980 Jan-Mar 22; 22(1):1-5. PubMed ID: 7413229
    [No Abstract]   [Full Text] [Related]  

  • 4. [Observations on changes in the leukocyte pattern and methodical studies of the LE cell phenomenon in disseminated lupus erythematodes].
    Hoigné R; Bütikofer E; Vögeli H
    Schweiz Med Wochenschr; 1966 Sep; 96(37):1229-32. PubMed ID: 4171965
    [No Abstract]   [Full Text] [Related]  

  • 5. Lupus anticoagulant in drug-induced systemic lupus erythematosus (SLE).
    Gastineau DA; Holcomb GR
    Arch Intern Med; 1985 Oct; 145(10):1926-7. PubMed ID: 3929709
    [No Abstract]   [Full Text] [Related]  

  • 6. Premature telomere shortening in polymorphonuclear neutrophils from patients with systemic lupus erythematosus is related to the lupus disease activity.
    Wu CH; Hsieh SC; Li KJ; Lu MC; Yu CL
    Lupus; 2007; 16(4):265-72. PubMed ID: 17439933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.
    McManus LM; Hanahan DJ; Demopoulos CA; Pinckard RN
    J Immunol; 1980 Jun; 124(6):2919-24. PubMed ID: 7373056
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic lupus erythematosus VI: Hematologic and serologic abnormalities.
    Meyerhoff J
    Md State Med J; 1983 Dec; 32(12):935-9. PubMed ID: 6664125
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pathogenesis of leukopenia in systemic lupus erythematosus (I). Effect of prednisolone on colony forming units in culture (CFU-C) growth in patients with systemic lupus erythematosus (SLE)].
    Sugimoto M; Wakabayashi Y; Shiokawa Y; Takaku F
    Nihon Ketsueki Gakkai Zasshi; 1982 May; 45(3):594-9. PubMed ID: 7136458
    [No Abstract]   [Full Text] [Related]  

  • 10. [Basophils in lupus erythematosus and other dermatoses].
    Hunziker N; Brun R
    Dermatologica; 1972; 145(4):291-6. PubMed ID: 4269235
    [No Abstract]   [Full Text] [Related]  

  • 11. Release of platelet-activating factor in human pathology. I. Evidence for the occurrence of basophil degranulation and release of platelet-activating factor in systemic lupus erythematosus.
    Camussi G; Tetta C; Coda R; Benveniste J
    Lab Invest; 1981 Mar; 44(3):241-51. PubMed ID: 7464048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal platelet function by acquired circulating factor VIII inhibitor in a patient with systemic lupus erythematosus.
    Cortellaro M; Pogliani E; Cofrancesco E
    Haematologica; 1977 Jun; 62(3):241-9. PubMed ID: 408237
    [No Abstract]   [Full Text] [Related]  

  • 13. Neutrophil and platelet interactions in "allergic" and inflammatory reactions: a role for acetyl glyceryl ether phosphorylcholine (platelet-activating factor).
    Henson PM; Betz SJ
    Kroc Found Ser; 1981; 14():51-66. PubMed ID: 6947075
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus.
    Ren Y; Tang J; Mok MY; Chan AW; Wu A; Lau CS
    Arthritis Rheum; 2003 Oct; 48(10):2888-97. PubMed ID: 14558095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hematological abnormalities in systemic lupus erythematosus and clinical significance thereof: comparative analysis of 236 cases].
    Chen JL; Huang XM; Zeng XJ; Wang Y; Zhou MX; Ma YH; Li RS; Shen T
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1330-3. PubMed ID: 17727778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior of leukocytes and antileukocytic antibodies in lupus erythematosus].
    Sönnichsen N; Haustein UF
    Dermatol Wochenschr; 1967 Nov; 153(46):1266-71. PubMed ID: 5588905
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody against platelet membrane glycoprotein VI in a patient with systemic lupus erythematosus.
    Takahashi H; Moroi M
    Am J Hematol; 2001 Aug; 67(4):262-7. PubMed ID: 11443641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet and plasma serotonin in glomerulonephritis. III: The nephritis of systemic lupus erythematosus.
    Parbtani A; Frampton G; Yewdall V; Kasai N; Cameron JS
    Clin Nephrol; 1980 Oct; 14(4):164-72. PubMed ID: 7428190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human neutrophil-derived platelet activating factor.
    Lotner GZ; Lynch JM; Betz SJ; Henson PM
    J Immunol; 1980 Feb; 124(2):676-84. PubMed ID: 7356708
    [No Abstract]   [Full Text] [Related]  

  • 20. The release of platelet-activating factor during phagocytosis by polymorphonuclear neutrophils and monocytes.
    Camussi G; Bussolino F; Aglietta M; Piacibello W; Tetta C; Segoloni G
    Adv Exp Med Biol; 1982; 141():259-68. PubMed ID: 7090917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.